A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece for fitting to a nostril of a subject, wherein the nosepiece comprises a tip element which includes a delivery aperture from which substance is in use delivered into the nasal cavity, and the tip element is at least in part tapered such as to be inclined to a longitudinal axis of the nosepiece, with the delivery aperture extending both laterally across the tip element and along a longitudinal extent of the tip element; a nozzle through which substance is in use delivered, preferably substantially axially to a longitudinal axis of the nosepiece, to the respective nasal cavity; and a delivery unit for delivering substance through the nozzle of the nosepiece.

A nasal respiratory delivery device includes fabric pads or fabric domes that cover the nostrils and includes a plastic strip with skin-sensitive adhesive for attachment of the device to the septum and the outside of each nostril, and provides for suppressing the human cough via moistening and warming inhaled air, thus soothing the respiratory passageways and mitigating the cough reflex. The nasal respiratory delivery device also provides for cough suppressants, nasal decongestants or other medical or breathing treatments. The nasal respiratory delivery device is placed across both nasal openings and adhered to the nasal septum and to the tissue surrounding the nostrils. The fabric pads or fabric domes are composed of nonwoven or woven manmade and/or natural materials that absorb and provide moisture or therapeutic agents during the act of breathing.

A wearable intranasal device that dispenses concentrated oils, specifically Aromatherapy and Cannabidiol or CBD, allowing each to evaporate naturally through the nasal cavity providing temporary relief of a variety of symptoms these products have been positively found to impact. The device is a single unit consisting of two barrels on both ends joined by a bridging center arch and which will hug the septum of the user ergonomically not causing any irritation to the user. Each barrel receives a cotton wick which will hold the concentrated oil(s).

A method for delivering nitric oxide therapy to a subject can include administering a composition including a nitric-oxide releasing agent and silica to the subject and releasing a therapeutic amount of nitric oxide from the composition.

A device for treating nasal congestion and/or relieving sinusitis symptoms in a patient comprises: a vibration generator, a fastener configured to attach the vibrator to a location adjacent to the patient's nasal cavity, nasal passageway or sinuses and a generator of a fluid stream which delivers the fluid stream to the respiratory tract of the patient. The vibration includes a motor, an eccentric member rotatable by the motor and an impact member mechanically linked to the eccentric member such that the impact member is vibratable by the eccentric member.

Disclosed herein are facial covering that are configured to be placed on facial skin and that may be placed on the skin in a sealed relationship such that air leakage is minimized. The covering may include a member configured to fit flush against skin surrounding at least one of nasal air passages and a mouth of a user, the member including at least one aperture to permit breathing through the nasal air passages, the member being configured to adhere to the skin; and filter material positioned within a space defined by the at least one aperture.

A nasal administration device is disclosed which enables delivery of a well collimated stream of medication through the nasal orifice of a human being to the pharyngeal orifice of the eustachian tube. The device utilizes alignment tabs to properly position the collimated stream utilizing facial landmarks and an alignment arrow to confirm such alignment. Certain preferred embodiments of the disclosed device include adjustable alignment tabs enabling more precise alignment for a range of facial profiles.

An atomizer comprises an atomizing body, an atomizing assembly, an atomizing base and a fixing member. The atomizing base is disposed in one end of the atomizing body. The fixing member is installed outside the atomizing base and connected with the atomizing body. The fixing member is made of metal magnetic material.

An intra-nasal clip device may include a retainer having a first arm and a second arm. A first chamber housing may be coupled to the first arm, and the first chamber housing may include a first chamber and a first contact surface. Preferably, the first chamber and the first contact surface may be positioned on opposing sides of the first chamber housing. A second chamber housing may be coupled to the second arm, and the second chamber housing may include a second chamber and a second contact surface. Preferably, the second chamber and second contact surface may be positioned on opposing sides of the second chamber housing. The first contact surface and second contact surface may be orientated towards each other and configured to contact and grip portions of the nose so that a chamber, optionally containing an aromatic compound, may be positioned within a nostril of the nose.

A system for delivering a therapeutic agent to nasopharyngeal mucosa tissue has a shaft, a porous pad of compliant material coupled to the shaft near the distal end, and a drug reservoir. The porous pad is configured to expand from a contracted configuration to an expanded configuration. The expanded configuration is adapted to engage and conform to the mucosa tissue in a nasal cavity, and the contracted configuration has a size suitable for introduction into the nasal cavity. The drug reservoir holds a therapeutic agent and is at least partially covered by the porous pad. The drug reservoir is configured to release a fixed volume of the therapeutic agent into the porous pad within a period of less than about 120 minutes, and has a wall with a plurality of channels fluidly coupled with the porous pad.